Special Issue "Pharmaceutical Crystallisation Science and Engineering"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (30 November 2017)
Dr. Tariq Mahmud
Crystallisation plays an essential role in the pharmaceutical industry, in which it is, not only used to isolate and purify Active Pharmaceutical Ingredients (APIs), but also offers a molecular approach to modify APIs in order to achieve desired properties, such as crystal size and shape, polymorphs, solvates, salts, and co-crystals. This requires careful design and optimisation of crystallisation processes. However, a significant gap in the knowledge exists for designing such optimal systems, in particular the relationship between the fundamentals of crystallisation kinetics, i.e., nucleation and crystal growth, with the observed performance and behaviour of the APIs. The aim of this Special Issue of Pharmaceutics journal is to provide a platform to report recent developmentof fundamental knowledge in pharmaceutical crystallisation science and engineering by researchers in the industry and academia from around the world. This Special Issue will focus on the crystallisation fundamentals including nucleation, crystal growth and structure; different types of crystals and their crystallisation environment; crystallisation modelling from molecular to process scales; and industrial crystallisation process development, scale up, measurement and control.
Prof. Dr. Mingzhong Li
Dr. Tariq Mahmud
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Fundamentals of nucleation and crystal growth
- Types of crystals and crystallisation environment
- Techniques for crystallisation characterisation
- Crystallisation modelling across length scales
- Industrial crystallisation processes
- Pharmaceutical co-crystals
- Crystallisation modelling and control